{{cardData.Tag}}
{{cardData.CtaText}}
{{cardData.Title}}
{{cardData.TimeSignatureField}}
Video transcript
{{cardData.Tag}}
{{cardData.CtaText}}
{{cardData.Title}}
{{cardData.TimeSignatureField}}
Video transcript
{{cardData.Tag}}
{{cardData.CtaText}}
{{cardData.Title}}
{{cardData.TimeSignatureField}}
Video transcript
{{cardData.Tag}}
{{cardData.CtaText}}
{{cardData.Title}}
{{cardData.TimeSignatureField}}
Video transcript
-
Kirkland Advises Veriforce on Acquisition of Highwire, Expanding Leadership in Contractor Risk Management
- For Fifth Straight Year, Kirkland Named Among Law360’s Prestige Leaders
- Kirkland Recognized Among Newsweek’s Most Reliable Companies 2026
- Partner Rodin Hai-Jew Among Daily Journal’s “40 Under 40”
- Kirkland Represents Blue Owl on Joint Venture with Meta to Develop Hyperion Data Center
- Kirkland Advises Rockcliff Energy III on Acquisition of East Texas Assets from Pine Wave Energy Partners
- Merger and Acquisition Attorney of the Year Finalist: Armand Della Monica, Kirkland & Ellis
- Kirkland Advises Blackstone and TPG on up to $18.3 Billion Acquisition of Hologic
- Leading Sports Attorney Jason Krochak Joins Kirkland & Ellis
- Kirkland Advises KKR on Launch of Galaxy Container Solutions
- Kirkland Advises Switch on $659 Million Asset-Backed Securities Offering
- Rising Trial Star Kuan Huang Returns to Kirkland
- Kirkland Represents Kohlberg & Company and PCI Pharma Services in Debt and Preferred Equity Financing Aspects of Strategic Investment Transaction
- Kirkland Advises 26North on Investment in NEP Group
- Kirkland Advises Warburg Pincus on Entering Exclusive Negotiations to Acquire Significant Minority Stake in Sebia
- Kirkland Represents CBC Group on Successful Closing of Second Healthcare Royalty Fund
- Partner Rebecca Perlman Named a Forward Law Review “Forward 40”
- Kirkland Advises Apex Clean Energy on $1.05 Billion Refinancing
- Kirkland Advises Lone Star on $3.8 Billion Acquisition of Hillenbrand
- Kirkland Advises Sihuan Pharm and Xuanzhu Biopharm on Successful Spin-off and Separate Listing of Xuanzhu Biopharm